Literature DB >> 4547573

Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cells.

V A Bokisch, A T Sobel.   

Abstract

This report describes receptors for C4b on human peripheral B lymphocytes. The simultaneous presence of C3b and C4b receptors on the same lymphocytes was demonstrated by the formation of mixed rosettes consisting of the lymphocytes, EAC14 and EAC1423. Furthermore, reduction of the number of EAC1423 rosette-forming lymphocytes in a lymphocyte population by albumin gradient centrifugation concomitantly reduced EAC14 rosette-forming lymphocytes. Binding of EAC14 intermediates to receptors on human lymphocytes and erythrocytes could be inhibited by equal amounts of soluble C3b or C4b, suggesting the presence of a single receptor for both ligands on those cells. In contrast, the results of the rosette assay with Raji cells, cultured human lymphoblastoid cells, EAC14 and EAC1423 suggested that the receptors for C4b and C3b are distinct entities, since Raji cells formed rosettes with EAC1423, but not with EAC14. Moreover, this report demonstrates a cooperation of erythrocyte-bound C4b and C3b in the binding of EAC1423 to B lymphocytes. In contrast to KAF-treated C3b, KAF-treated C4b did not bind to B lymphocytes, indicating that these cells lack a receptor for C4d.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4547573      PMCID: PMC2139732          DOI: 10.1084/jem.140.5.1336

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

2.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

3.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

4.  The adherence of leucocytes and platelets induced by fixed IgG antibody or complement.

Authors:  P M Henson
Journal:  Immunology       Date:  1969-01       Impact factor: 7.397

5.  The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.

Authors:  P J Lachmann; H J Müller-Eberhard
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

6.  Human lymphoblastoid lines from lymph node and spleen.

Authors:  J A Levy; M Virolainen; V Defendi
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

7.  Cleavage of the fourth component of human complement (C4) by C1 esterase: isolation and characteristics of the low molecular weight product.

Authors:  D B Budzko; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1970-02

8.  Immune adherence by the fourth component of complement.

Authors:  N R Cooper
Journal:  Science       Date:  1969-07-25       Impact factor: 47.728

9.  Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.

Authors:  V A Bokisch; H J Müller-Eberhard; C G Cochrane
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

10.  Receptors for complement of leukocytes.

Authors:  W H Lay; V Nussenzweig
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  20 in total

1.  Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.

Authors:  S Gupta; R A Good; F P Siegal
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

2.  Complement bridges between cells analysis of a possible cell-cell interaction mechanism.

Authors:  M P Dierich; B Landen
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

3.  Receptors for complement components in inflammation.

Authors:  A Sobel; C Blanc; A Cattaneo; M Moisy; M Lopez-Trascasa; J J Bourgarit; Y Gabay
Journal:  Agents Actions       Date:  1983-08

Review 4.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

Review 5.  Factors influencing immune complex localisation.

Authors:  L Schrieber; R Penny
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Evidence that the fourth component of complement (C4) is carried on a high proportion of normal guinea-pig B lymphocytes.

Authors:  A B Wilson; S Prichard-Thomas; R R Coombs
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

7.  B-cell lymphoma lacking Fc- and C3d-receptors.

Authors:  E Thiel
Journal:  Blut       Date:  1978-12-15

8.  Binding of immunoglobulin- and complement-coated erythrocytes to human neutrophil subpopulations.

Authors:  S C Whited; M Santaella; M M Frank; T Gaither; J I Gallin
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

9.  Effect of corticosteroids on the human monocyte IgG and complement receptors.

Authors:  A D Schreiber; J Parsons; P McDermott; R A Cooper
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Inhibition of complement-dependent lymphocyte rosette formation by sera of patients with chronic glomerulonephritis.

Authors:  J C Gluckman; H Beaufils; F Sanchez
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.